ES8401926A1 - Un procedimiento para la preparacion de un compuesto de hidroxibencilaminobenceno, dotado de propiedades antiinflamatorias. - Google Patents

Un procedimiento para la preparacion de un compuesto de hidroxibencilaminobenceno, dotado de propiedades antiinflamatorias.

Info

Publication number
ES8401926A1
ES8401926A1 ES517995A ES517995A ES8401926A1 ES 8401926 A1 ES8401926 A1 ES 8401926A1 ES 517995 A ES517995 A ES 517995A ES 517995 A ES517995 A ES 517995A ES 8401926 A1 ES8401926 A1 ES 8401926A1
Authority
ES
Spain
Prior art keywords
hydroxybenzylamino
preparing
same
pharmaceutical compositions
compositions containing
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
ES517995A
Other languages
English (en)
Other versions
ES517995A0 (es
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Merck and Co Inc
Original Assignee
Merck and Co Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merck and Co Inc filed Critical Merck and Co Inc
Publication of ES517995A0 publication Critical patent/ES517995A0/es
Publication of ES8401926A1 publication Critical patent/ES8401926A1/es
Expired legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/72—Nitrogen atoms
    • C07D213/74—Amino or imino radicals substituted by hydrocarbon or substituted hydrocarbon radicals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
    • C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
    • C07D215/16—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D215/38—Nitrogen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D285/00—Heterocyclic compounds containing rings having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by groups C07D275/00 - C07D283/00
    • C07D285/01—Five-membered rings
    • C07D285/02—Thiadiazoles; Hydrogenated thiadiazoles
    • C07D285/04—Thiadiazoles; Hydrogenated thiadiazoles not condensed with other rings
    • C07D285/10—1,2,5-Thiadiazoles; Hydrogenated 1,2,5-thiadiazoles

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Quinoline Compounds (AREA)
  • Pyridine Compounds (AREA)

Abstract

PROCEDIMIENTO PARA LA OBTENCION DE DERIVADOS DE HIDROXIBENCILAMINOBENCENO, DE FORMULA (I), EN LA QUE R Y R PUEDEN SER VARIOS TIPOS DE RADICALES; Y N VALE 1 O 2; COMPUESTOS QUE TIENEN APLICACIONES FARMACOLOGICAS POR SUS PROPIEDADES ANTIINFLAMATORIAS.CONSISTE EN LA REACCION DE UN DERIVADO DE 2-HIDROXIBENZALDEHIDO, DE FORMULA (II) CON UNA AMINA DE FORMULA RNH2, EN LAS QUE R Y R TIENEN EL MISMO SIGNIFICADO QUE EN LA FORMULA (I), EN UN DISOLVENTE INERTE, A UNA TEMPERATURA ENTRE 0JC Y 25JC; SEGUIDA DEL TRATAMIENTO DE LA BASE DE SCHIFF FORMADA CON UN AGENTE REDUCTOR, TAL COMO HIDROGENO EN PRESENCIADE PALADIO SOBRE CARBON O HIDRURO METALICOS MIXTOS, EN UN DISOLVENTE INERTE, A TEMPERATURAS ENTRE 0JC Y 30JC.
ES517995A 1981-12-14 1982-12-07 Un procedimiento para la preparacion de un compuesto de hidroxibencilaminobenceno, dotado de propiedades antiinflamatorias. Expired ES8401926A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US33054281A 1981-12-14 1981-12-14

Publications (2)

Publication Number Publication Date
ES517995A0 ES517995A0 (es) 1984-01-16
ES8401926A1 true ES8401926A1 (es) 1984-01-16

Family

ID=23290219

Family Applications (1)

Application Number Title Priority Date Filing Date
ES517995A Expired ES8401926A1 (es) 1981-12-14 1982-12-07 Un procedimiento para la preparacion de un compuesto de hidroxibencilaminobenceno, dotado de propiedades antiinflamatorias.

Country Status (8)

Country Link
EP (1) EP0081782B1 (es)
JP (1) JPS58109452A (es)
AT (1) ATE16278T1 (es)
CA (1) CA1219587A (es)
DE (1) DE3267188D1 (es)
DK (1) DK552682A (es)
ES (1) ES8401926A1 (es)
GR (1) GR77088B (es)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB2262524A (en) * 1991-12-18 1993-06-23 Sandoz Ltd Pharmaceutically active 2-hydroxy-benzylamines
US5672709A (en) * 1994-10-24 1997-09-30 Eli Lilly And Company Heterocyclic compounds and their preparation and use
AU704544B2 (en) * 1995-03-14 1999-04-29 Novartis Ag Trisubstituted phenyl derivatives
TW436483B (en) * 1997-08-19 2001-05-28 Otsuka Pharma Co Ltd Carbostyril derivatives, process for their preparation and pharmaceutical composition or cosmetic composition for inhibiting skin erythema and/or skin pigmentation
KR101088557B1 (ko) * 2000-12-18 2011-12-05 가부시키가이샤 이야쿠 분지 셋케이 겐쿠쇼 염증성 사이토카인 생산 유리 억제제
CA2487891A1 (en) * 2002-06-05 2003-12-18 Institute Of Medicinal Molecular Design, Inc. Inhibitors against the activation of ap-1 and nfat
TW200402291A (en) 2002-06-06 2004-02-16 Inst Med Molecular Design Inc Antiallergic
CA2488363C (en) 2002-06-06 2011-01-04 Institute Of Medicinal Molecular Design, Inc. O-substituted hydroxyaryl derivatives
US7671058B2 (en) 2006-06-21 2010-03-02 Institute Of Medicinal Molecular Design, Inc. N-(3,4-disubstituted phenyl) salicylamide derivatives

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2784138A (en) * 1953-03-07 1957-03-05 Bayer Ag Fungicidal compositions of nu-arylhydroxyarylmethylamines
AT332863B (de) * 1973-01-02 1976-10-25 Gerot Pharmazeutika Verfahren zur herstellung von neuen 2-aminomethyl-4,6-dihalogenphenolderivaten sowie deren additionssalzen mit sauren

Also Published As

Publication number Publication date
DE3267188D1 (en) 1985-12-05
EP0081782B1 (en) 1985-10-30
CA1219587A (en) 1987-03-24
GR77088B (es) 1984-09-06
ES517995A0 (es) 1984-01-16
DK552682A (da) 1983-06-15
EP0081782A1 (en) 1983-06-22
ATE16278T1 (de) 1985-11-15
JPS58109452A (ja) 1983-06-29

Similar Documents

Publication Publication Date Title
GB1432576A (en) Substituted phenylacetic acids
ES483767A1 (es) Procedimiento para producir n-arilsulfonil-l-argininamidas
ES8401468A1 (es) Un procedimiento para preparar derivados de nicotinamida.
GR3005315T3 (es)
IE45256L (en) Quinazolone derivatives
ES481729A1 (es) Procedimiento para la preparacion de derivados de 1,2-dihi- droquinolein-2-onas.
ES8406467A1 (es) "procedimiento para preparar nuevos benzo b tiofenos".
ES8302001A1 (es) Un procedimiento para la preparacion de nuevos derivados de cefalospirina.
ES8401926A1 (es) Un procedimiento para la preparacion de un compuesto de hidroxibencilaminobenceno, dotado de propiedades antiinflamatorias.
ES460286A1 (es) Un procedimiento de preparacion de espiro(1,3-dioxolan-4,3) quinuclidina.
ES482675A1 (es) Un procedimiento para la preparacion de nuevos derivados de oxadiazolopirimidina.
JPS5746990A (en) Novel cephalexin derivative and its preparation
ATE13302T1 (de) 3-o-demethyl-derivate von verbindungen der istamycin b-serie und ihre herstellung.
GB1290841A (es)
ES8301888A1 (es) "procedimiento para la preparacion de derivados de fenoxi-aminopropanol substituidos" como divisional de la patente de invencion n 502.649 del 1 junio 1981.
JPS5297934A (en) N#-arylsulfonyl-l-argininamides and their salts acceptable as medicine s
ES472295A1 (es) Procedimiento de obtencion de nuevas acilureas con actividadfarmacologica
ES482194A1 (es) Procedimiento para la obtencion de compuestos de acido 7- aminotiazolilacetamido-3-cefem-4-carboxilico.
ES479033A1 (es) Un procedimiento para la preparacion de derivados de n-iminometil piperidina.
GB1457911A (en) Guanyl-hydrazones
ES8206534A1 (es) Un procedimiento para la preparacion de derivados acilicos de cefalosporina
ES8106877A1 (es) Un procedimiento para preparar un derivado de dibenzo (a,d) ciclohepteno
JPS5585568A (en) Quinolinone-imine derivative and its preparation
GB1513974A (en) Benzoic acid derivatives
GB1462487A (en) Piperidine derivatives